As of Apr 28
| +0.24 / +0.74%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 81.50, with a high estimate of 235.00 and a low estimate of 36.00. The median estimate represents a +150.62% increase from the last price of 32.52.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.